Amongst oncologists, there’s a consensus on the subject of mantle cell lymphoma: no patient is the same. Therefore, there is no standard of care for treating mantle cell lymphoma (MCL). Instead, treatment should be individualized for each patient based on a number of patient and dise...
Mantle cell lymphomaFrontline treatmentClinical trialsNovel agentsMantle cell lymphoma (MCL) is a rare and incurable subtype of non-Hodgkin's lymphoma that generally affects older individuals. However, the use of high-dose therapy and autologous stem cell transplant has improved significantly the ...
Mantle cell lymphoma (MCL) is a B-cell lymphoma charac- terized by the t(11;14) translocation and cyclin D1 overex-pression that comprises 3% to 6% of non-Hodgkin lympho- mas. MCL is an aggressive entity with a median survival of only 3 to 4 years. Several new therape...
Mantle cell lymphomaautologous stem cell transplantchemotherapylymphomaminimal residual diseaseMantle cell lymphoma (MCL) has historically borne a poor prognosis, though recent developments such as intensified induction with autologous stem celltransplant (ASCT) consolidation for younger pa......
This review provides an extensive overview of the current frontline therapy trials for MCL and presents the results of innovative regimen, including some integrating novel agents and desintensified chemotherapy. 展开 关键词: Mantle cell lymphoma Frontline treatment Clinical trials Novel agents ...
Mantle cell lymphoma: the promise of new treatment options. Though the expected overall survival (OS) for mantle cell lymphoma (MCL) has doubled in the last 30 years it is still in the range of only 4鈥 5 years. Desp... A Goy,B Kahl - 《Critical Reviews in Oncology/hematology》 被...
Zanubrutinib, obinutuzumab, and venetoclax delivered promising response and survival data for the treatment of patients with mantle cell lymphoma harboring a TP53 mutation. Read More The Road to Improving Diffuse Large B-Cell Lymphoma Treatment ...
Updates in the Treatment of B-cell Lymphoma: Focus on Mantle Cell Lymphoma, Follicular Lymphoma, and Marginal Zone Lymphoma : Episode 12 Video February 18, 2022 Frontline Treatment Options for Marginal Zone Lymphoma Author(s): Bijal D. Shah, MD,Caron Jacobson, MD+3 MoreShared insight on ...
Recent Updates in the Treatment of Follicular Lymphoma and Mantle Cell Lymphoma : Episode 13 Opinion Video February 6, 2024 ASH 2023 Updates on Frontline Therapies in MCL Author(s): Grzegorz S. Nowakowski, MD,Jennifer Crombie, MD+4 MoreA panel of experts review latest data from ASH 2023 on...
Kahl. (2015) Mantle Cell Lymphoma: First-line Therapy in Patients Not Eligible for Stem Cell Transplantation. Current Treatment Options in Oncology 16 /... M Nazeef,BS Kahl - 《Current Treatment Options in Oncology》 被引量: 5发表: 2015年 Treatment of patients with multiple myeloma who are ...